In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 2 with Decreased Susceptibility to Lopinavir

Lopinavir (LPV)-ritonavir has demonstrated durable antiviral activity in human immunodeficiency virus type 1 (HIV-1)-infected antiretroviral-naïve and protease inhibitor (PI)-experienced patients. However, information on LPV activity against HIV-2 and the patterns of mutations in HIV-2 in response t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Masse, Sherie, Lu, Xiaozhi, Dekhtyar, Tatyana, Lu, Liangjun, Koev, Gennadiy, Gao, Feng, Mo, Hongmei, Kempf, Dale, Bernstein, Barry, Hanna, George J., Molla, Akhteruzzaman
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2007
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2043247/
https://ncbi.nlm.nih.gov/pubmed/17576848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00146-07
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires